129 related articles for article (PubMed ID: 2860954)
21. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
Nishi K; Kondo T; Narabayashi H
Brain Res; 1989 Jun; 489(1):157-62. PubMed ID: 2568151
[TBL] [Abstract][Full Text] [Related]
22. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Gessner W; Brossi A; Shen R; Abell CW
J Med Chem; 1985 Mar; 28(3):311-7. PubMed ID: 3871859
[TBL] [Abstract][Full Text] [Related]
25. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Melamed E; Rosenthal J; Globus M; Cohen O; Uzzan A
Brain Res; 1985 Sep; 342(2):401-4. PubMed ID: 3876139
[TBL] [Abstract][Full Text] [Related]
26. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
Ambrosio S; Gerli P; Perego C; Algeri S
Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
[TBL] [Abstract][Full Text] [Related]
27. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
Wolf ME; Galloway MP; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
[TBL] [Abstract][Full Text] [Related]
28. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
29. Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Nagatsu T
Toxicology; 2005 Dec; 216(1):9-14. PubMed ID: 16115719
[TBL] [Abstract][Full Text] [Related]
30. Effects of nomifensine and its metabolites on dihydropteridine reductase.
Shen RS; Sheng WL; Abell CW
J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
[TBL] [Abstract][Full Text] [Related]
31. Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens.
Missale C; Castelletti L; Govoni S; Spano PF; Trabucchi M; Hanbauer I
J Neurochem; 1985 Jul; 45(1):51-6. PubMed ID: 3998732
[TBL] [Abstract][Full Text] [Related]
32. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
33. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
Johnson EA; Tsai CE; Shahan YH; Azzaro AJ
J Pharmacol Exp Ther; 1993 Jul; 266(1):133-41. PubMed ID: 8101215
[TBL] [Abstract][Full Text] [Related]
34. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
Mizukawa K; Ogawa N; Sora YH
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
Lau YS; Fung YK
Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026
[TBL] [Abstract][Full Text] [Related]
36. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
[TBL] [Abstract][Full Text] [Related]
37. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
[TBL] [Abstract][Full Text] [Related]
38. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices.
Kurstjens NP; Cantrill RC
Eur J Pharmacol; 1989 Oct; 169(1):147-52. PubMed ID: 2574687
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
40. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
